Alteogen알테오젠
196170 · KOSDAQ · ₩196170 · 알테오젠
₩220,000▼ ₩3,000 (1.35%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩69B | ₩72B | ₩65B | ₩49B | ₩19B | ₩84B | ₩51B | ₩4.9B |
| Cost of sales | ₩7.4B | ₩10B | ₩22B | ₩9.2B | ₩6.6B | ₩13B | ₩18B | ₩3B |
| Gross profit | ₩61B | ₩62B | ₩43B | ₩40B | ₩12B | ₩71B | ₩33B | ₩1.9B |
| Operating income | ₩34B | ₩39B | ₩20B | ₩27B | −₩426M | ₩61B | ₩23B | −₩8.2B |
| Net income | ₩30B | ₩71B | ₩74B | ₩22B | −₩34B | ₩83B | ₩70B | −₩6.3B |
| Net income to shareholders | ₩28B | ₩72B | ₩71B | ₩22B | −₩34B | ₩83B | ₩70B | −₩6.3B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩740B | ₩729B | ₩699B | ₩639B | ₩603B | ₩650B | ₩409B | ₩299B |
| Current assets | ₩522B | ₩512B | ₩481B | ₩442B | ₩408B | ₩425B | ₩212B | ₩167B |
| Cash and equivalents | ₩80B | ₩42B | ₩66B | ₩52B | ₩64B | ₩45B | ₩19B | ₩27B |
| Total liabilities | ₩193B | ₩217B | ₩244B | ₩262B | ₩255B | ₩276B | ₩135B | ₩122B |
| Current liabilities | ₩189B | ₩212B | ₩240B | ₩256B | ₩250B | ₩114B | ₩129B | ₩108B |
| Borrowings | ₩4.9B | ₩6.7B | ₩6.6B | ₩5.9B | ₩6.5B | ₩6.4B | ₩6.4B | ₩11B |
| Total equity | ₩547B | ₩513B | ₩454B | ₩378B | ₩348B | ₩375B | ₩274B | ₩177B |
| Shareholders' equity | ₩536B | ₩504B | ₩445B | ₩374B | ₩343B | ₩368B | ₩274B | ₩177B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩17B | ₩21B | ₩65B | −₩4.9B | ₩69B | −₩4.8B | ₩23B | −₩509M |
| Capital spending | ₩2.4B | ₩14B | ₩15B | ₩5.7B | ₩1.5B | ₩875M | ₩1.1B | ₩1B |
| Free cash flow | ₩14B | ₩7.1B | ₩50B | −₩11B | ₩67B | −₩5.7B | ₩22B | −₩1.6B |
| Dividends paid | ₩0 | ₩20B | — | — | — | — | — | — |
Consolidated where available. Amounts in won.
Also known as: Alteogen / 알테오젠 / 196170 / KRX:196170
Source: KRX statistical information